Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Cyteir Therapeutics, Inc. (CYTT) had Free Cash Flow per Share of $-0.52 for the most recently reported fiscal quarter, ending 2023-09-30.
| Income Statement Financials | |
-- |
|
$-3.53M |
|
-- |
|
-- |
|
$5.17M |
|
$-5.17M |
|
$1.64M |
|
$-3.53M |
|
$-3.53M |
|
$-3.53M |
|
$-3.53M |
|
$-3.53M |
|
$-3.53M |
|
$-5.17M |
|
$-5.06M |
|
36.03M |
|
36.03M |
|
$-0.10 |
|
$-0.10 |
|
| Balance Sheet Financials | |
$130.64M |
|
$0.10M |
|
$0.37M |
|
$131.01M |
|
$5.97M |
|
-- |
|
$0.01M |
|
$5.98M |
|
$125.03M |
|
$125.03M |
|
$125.03M |
|
36.08M |
|
| Cash Flow Statement Financials | |
$-18.87M |
|
$0.30M |
|
$0.69M |
|
$147.38M |
|
$129.50M |
|
$-17.87M |
|
$2.42M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
21.89 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-18.57M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-2.82% |
|
-2.82% |
|
-2.70% |
|
-2.82% |
|
$3.46 |
|
|
Free Cash Flow per Share |
$-0.52 |
$-0.52 |
|